IRADIMED CORPORATION IRMD Income Statement

Iradimed corporation (IRMD)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13	Jun'13
Revenue
38,757	38,517	35,965	33,617	31,768	30,438	28,804	26,879	25,027	23,081	22,366	24,350	28,694	32,496	35,305	35,825	33,566	31,593	26,377	21,996	19,087	15,653	14,549	13,512	0	0	0
Cost of revenue
8,982	8,816	8,056	7,715	7,567	7,211	6,869	6,350	5,873	5,569	5,233	5,331	5,836	6,154	6,350	6,535	6,218	5,840	5,259	4,628	4,076	3,404	3,155	2,963	0	0	0
Gross profit
29,775	29,700	27,909	25,901	24,200	23,227	21,935	20,529	19,153	17,511	17,133	19,018	22,858	26,341	28,954	29,290	27,348	25,753	21,118	17,367	15,011	12,248	11,393	10,548	0	0	0
Operating expenses:
General and administrative
10,901	10,451	9,629	9,202	8,820	8,710	8,716	9,085	9,197	9,001	8,426	7,744	8,643	8,795	9,358	9,164	8,061	7,769	6,960	6,547	5,692	4,816	4,126	3,391	0	0	0
Sales and marketing
9,492	9,169	8,656	8,144	7,460	6,995	6,509	5,976	5,784	5,502	5,179	5,273	5,360	5,278	5,345	5,205	4,900	4,705	4,191	3,866	3,626	3,297	3,018	2,633	0	0	0
Research and development
1,510	1,432	1,421	1,425	1,489	1,517	1,498	1,508	1,561	1,722	1,737	1,811	1,654	1,347	1,483	1,544	1,656	1,764	1,579	1,364	1,186	1,068	1,052	953	0	0	0
Total operating expenses
21,904	21,053	19,707	18,771	17,770	17,223	16,724	16,570	16,542	16,226	15,342	14,830	15,657	15,421	16,187	15,914	14,618	14,240	12,732	11,777	10,504	9,182	8,197	6,979	0	0	0
Income from operations
7,870	8,647	8,201	7,130	6,430	6,003	5,210	3,958	2,610	1,285	1,790	4,187	7,200	10,920	12,766	13,376	12,729	11,513	8,386	5,589	4,506	3,065	3,196	3,569	0	0	0
Other income, net
401	395	363	296	246	193	142	128	121	111	88	56	30	32	-13	55	106	121	102	29	-5	-48	25	56	0	0	0
Income before provision for income taxes
8,272	9,043	8,565	7,426	6,676	6,197	5,353	4,087	2,732	1,396	1,879	4,244	7,230	10,952	12,753	13,431	12,836	11,634	8,489	5,619	4,501	3,017	3,221	3,626	0	0	0
Provision for income tax benefit
-1,281	-587	468	-614	-631	-106	573	1,515	1,158	896	422	1,419	2,531	3,738	4,275	4,646	4,511	4,104	3,093	1,852	1,486	966	1,181	1,265	0	0	0
Net income
9,554	9,630	8,096	8,041	7,307	6,303	4,780	2,572	1,574	499	1,456	2,825	4,699	7,214	8,478	8,785	8,324	7,529	5,396	3,766	3,014	2,050	2,040	2,361	0	0	0
Change in fair value of available-for-sale securities, net of tax (benefit) expense of $(6,369) and $70 for the three months ended September 30, 2015 and 2014, respectively, and $(8,833) and $(2,681) for nine months ended September 30, 2015 and 2014, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-1	0	0	0
Realized gain on available-for-sale securities reclassified to net income, net of tax of $70 and $2,560 for the three and nine months ended September 30, 2014, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Comprehensive income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,043	2,359	0	0	0
Net income per share:
Basic (in dollars per share)
0.15	0.27	0.22	0.19	0.17	0.16	0.22	0.13	0.08	0.02	0.02	0.03	-0.02	0.10	0.15	0.21	0.21	0.21	0.17	0.16	0.14	-0.01	0.02	0.15	0.07	0.04	0.08
Diluted (in dollars per share)
0.14	0.26	0.20	0.17	0.15	0.14	0.20	0.11	0.07	0.01	0.02	0.03	-0.02	0.09	0.13	0.19	0.19	0.18	0.15	0.15	0.12	0.01	0.02	0.11	0.06	0.03	0.07
Weighted average shares outstanding:
Basic (in shares)
11,891	11,566	11,369	11,163	11,029	10,950	10,824	10,651	10,608	10,561	10,565	10,687	10,740	10,714	10,684	10,778	11,095	11,103	11,028	10,974	10,906	10,861	10,112	7,000	7,000	7,000	7,000
Diluted (in shares)
12,365	12,341	12,309	12,226	12,227	12,353	12,195	12,011	11,879	12,769	11,643	11,727	10,740	11,798	11,867	11,966	12,326	13,759	12,382	12,107	11,977	11,870	11,269	8,878	8,859	8,665	8,495